Historical Documents and STIC Tables

2024 USCAST Interpretive Tables

The 2025 edition of the USCAST STIC in a searchable PDF format can be downloaded.

Download

Aminoglycoside STIC Evaluations

Version 1.3, 2019

Download

2021 USCAST STIC Tables

The 2021 edition of USCAST STIC Tables contains breakpoints for hundreds of antimicrobials in a searchable PDF format that can be downloaded.

Download

2020 USCAST STIC Tables

This document shows the currently published susceptible breakpoints for three breakpoint determining organizations (USA-FDA, CLSI and EUCAST-SC) compared to those breakpoint criteria recommended by USCAST. Only four antimicrobial agent classes are presented (fluoroquinolones, aminoglycosides, oxazolidinones, peptides), those drug groups that have been most recently addressed by the USCAST process via official reports or where breakpoints were suggested at the time of regulatory approval in the USA or Europe. USCAST advocates an active harmonization process among these organizations to minimize discords between antimicrobial susceptibility test results produced in the USA and the rest of the world.

Download

Other Documents

Oritavancin​​ Rationale Document

Version 1.0, 2016

DOWNLOAD

Tedizolid​​ Rationale Document​

Version 1.0, 2016

DOWNLOAD

Dalbavancin Rationale Document

Version 1.1, 2018

DOWNLOAD

Telavancin Rationale Document

Version 1.0, 2016

DOWNLOAD

Report on Method Validation and Susceptibility Breakpoint Criteria for Testing Gonococci

Version 1.0, 2019

DOWNLOAD

USCAST Surrogate Guidance Testing Document

Version 1.1, 2018

DOWNLOAD